The Episodes below focuses on the quantitative presentation of efficacy and risk information in drug advertisements, especially in DTC (Direct to consumer) promotional materials. It highlights the importance of choosing the right format – such as absolute vs relative frequencies and maintaining consistency throughout the promotional material. It also interprets how consumers may misinterpret data and provides emphasis on the need for clear and contextual information. It encourages to use visual representations of data and present the risk and efficacy information in ways that enhance the understanding of consumers without minimizing risks or misleading consumers.
Episode 1
Why include control Group information in DTC Drug Ads?
Quantitative information about both treatment group and control group in DTC drug Ads helps the consumers in better understand the drug’s true efficacy and risks leading to more informed decisions. For more information, please check our video
Episode 2
How Should Efficacy & Risk be presented in DTC Drug Ads?
It is recommended that presenting efficacy risk data in absolute numbers e.g., (55 out of 100) or percentages (50%) helps the consumers to easily understand and recall the drugs benefits and risks without performing complex calculations. For more information, please check our video
Episode 3
Are Relative Frequencies Misleading in Drug Ads?
Consumers struggle to interpret date when provided relative frequency format e.g., “3 times more likely”. Presenting absolute numbers alongside helps avoid confusion and ensures clear understanding of efficacy and risk information. For more information, please check our video